Persevere Therapeutics
PrivateLast Round
Seed
Mar 4, 2026
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Persevere Therapeutics is an oncology biotechnology company that develops misetionamide, a novel antineoplastic therapeutic for patients with difficult-to-treat cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Persevere Therapeutics Comparables
Compare Persevere Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vortex Therapeutics, Inc. | 82% | |
| Peptomyc | 74% | |
| Jazz Pharmaceuticals | 59% | |
Persevere Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Mar 4, 2026 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 4, 2026
$1.6M raised in Seed round.
Persevere Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Persevere Therapeutics's valuation, stock price, and market status.